Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Overview
Date Founded

1944

Headquarters

5 Basel Street,Petach Tikva, HaMerkaz 49131

Type of Company

Public

Employees (Worldwide)

42.5K

Industries

Pharmaceuticals
Hospitals & Patient Services
Wholesale: Consumer Non-Durables/Sundries
Other Business & Consulting Services
Medical Support Services
Internet Software & Services
Biotechnology

Company Description

Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence

Contact Data
Trying to get in touch with decision makers at Teva Pharmaceutical Industries Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Chief Integration Officer

Senior Vice President, Chief Accounting Officer

Executive Vice President, Chief Legal Officer

Chief Executive Officer-Supply Chain Services Unit

Senior Director, Investor Relations

Executive Vice President, Global Brand & Communications

Executive Vice President, Global Operations

Executive Vice President, Chief Human Resources Officer & Corporation Brand & Communications

Board of Directors

Founder at Centrexion Therapeutics Corp.

Founder at Bridger Management LLC

Former President & Chief Executive Officer at STRATA Skin Sciences, Inc.

Former President & Chief Operating Officer at AllianceBernstein LP

Chairman of the Board of Governors at Jerusalem College of Engineering

Former President & General Manager of Emerging Markets at Pfizer, Inc.

Former Senior Vice President, Administration & Assistant Secretary at Regeneron Pharmaceuticals, Inc.

Director, President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd.

Executive Partner, Private Equity at Sofinnova Ventures, Inc.

Managing General Partner & Co-Founder at Pitango Venture Capital

Paths to Teva Pharmaceutical Industries Ltd.
Potential Connections via
Relationship Science
You
Teva Pharmaceutical Industries Ltd.
Owners & Shareholders
Details Hidden

TGA's investment philosophy and approach are based on three tenets: value, patience and bottom-up selection. By combining time-proven fundamental analysis with original research, the investment team searches for companies that meet their criteria of quality and valuation. When choosing equity investments for the strategies, the investment manager applies a bottom-up, value-oriented, long-term approach, focusing on the market price of a company's securities relative to the firm's evaluation of the company's long-term earnings, asset value and cash flow potential. The managers then construct individual portfolios within established parameters for the mandate as well as diversification based in the research results. Portfolio managers continually review portfolios to assess sector and industry risk exposure in response to changing market conditions.

Details Hidden

Templeton Investment Counsel's equity strategies seek to identify stocks that are significantly undervalued in markets across the globe. By combining fundamental analysis with original research, they search for companies that meet their criteria of quality and valuation. When choosing equity investments for the strategies, the firm applies a bottom-up, value-oriented, long-term approach, focusing on the market price of a company's securities relative to the firm's evaluation of the company's long-term earnings, asset value and cash flow potential. Based on these research results, managers construct individual portfolios within established parameters for the mandate as well as diversification. Portfolio managers continually review portfolios to assess sector and industry risk exposure in response to changing market conditions. The Templeton Global Equity Group manages global, regional and single country equity products. The group has a flat management structure and is led by the Chief Investment Officer, who is responsible for all aspects of the Global Equity Group; the Director of Portfolio Management, who coordinates the global portfolio management activities of the group; and the Director of Research, who is responsible for the equity research process.

Details Hidden

Abrams Capital Management provides investment advisory services to privately-offered alternative investment funds. The funds' primary investment objective is to maximize long-term total returns in variable market and economic conditions, while emphasizing preservation of capital. Abrams Capital's investment strategy is opportunistic and follows a fundamental, value-oriented approach. Investments generally are made with a long-term time horizon and are generally unlevered and long-biased. Abrams Capital and their affiliates have acquired and liquidated investments across a wide spectrum of asset types, investment strategies, market sectors, market cycles and industries. This spectrum includes, but is not limited to, distressed securities, private and/or illiquid securities, investments in pooled investment vehicles managed by unaffiliated investment advisers, and domestic and foreign equity and debt securities.

Recent Transactions
Details Hidden

Eurolife Healthcare Pvt Ltd. purchases Teva Pharmaceutical Industries Ltd /Intravenous Infusions Bus from Teva Pharmaceutical Industries Ltd.

Details Hidden

PL Developments, Inc. purchases Teva Pharmaceutical Industries Ltd. /OTC Medicine Division from Teva Pharmaceutical Industries Ltd.

Details Hidden

CVC Advisers Ltd. purchases Theramex HQ UK Ltd. from Teva Pharmaceutical Industries Ltd.

Advisors & Consultants
Legal Advisor

Global Head of Intellectual Property & General Counsel for US at Hikma Pharmaceuticals Plc

Legal Advisor

Partner at Kirkland & Ellis LLP

Advisor

Chief Executive Officer at Hikma Pharmaceuticals Plc

Clients

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Key Stats and Financials As of 2018
Market Capitalization
$33.6B
Total Enterprise Value
$165B
Earnings Per Share
$-8.45
Revenue
$67.8B
Net Profit
$-7.73B
Total Equity
$59B
Total Debt
$108B
EBITDAMargin
24.99%
EBITDA
$16.9B
Enterprise Value Sales
2.44x
TEVNet Income
-21.38x
Debt TEV
0.65x
Three Year Compounded Annual Growth Rate Of Revenue
-3.84%
Five Year Compounded Annual Growth Rate Of Revenue
-1.55%
Enterprise Value EBITDAOperating
9.76x
Non-Profit Donations & Grants
Investments
Details Hidden

Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA.

Details Hidden

Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY.

Details Hidden

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Investors
Details Hidden

Managing Partner at Oak Investment Partners

Details Hidden

Berkshire Hathaway, Inc. is engaged in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, retailing, and services. It operates through following segments: GEICO, General Re, Berkshire Hathaway Reinsurance Group, Berkshire Hathaway Primary Group, Burlington Northern Santa Fe, LLC, Berkshire Hathaway Energy, McLane Company, Manufacturing, Service and Retailing, and Finance and Financial products. The GEICO segments involves in underwriting private passenger automobile insurance mainly by direct response methods. The General Re offers underwriting excess-of-loss, quota-share, and facultative reinsurance. The Berkshire Hathaway Reinsurance Group segment consists of underwriting excess-of-loss and quota-share reinsurance for insurers and reinsurers. The Berkshire Hathaway Primary Group segment comprises of underwriting multiple lines of property and casualty insurance policies. The BNSF segment operates railroad systems in North America. The Berkshire Hathaway Energy segments deals with regulated electric and gas utility, including power generation and distribution activities, and domestic real estate brokerage and brokerage franchisor. The McLane Company segment offers wholesale distribution of groceries and non-food items. The Manufacturing segment includes industrial and end-user products, building products, and apparel. The Service and Retailing segment involves providing fractional aircraft ownership programs, aviation pilot training, electronic components distribution, and retailing. The Finance and Financial Products segment includes manufactured housing and consumer financing; transportation equipment, manufacturing and leasing; and furniture leasing. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Details Hidden

Co-Founder at NellOne Therapeutics, Inc.

Suppliers
Antares Pharma, Inc. Medical Products & Equipment | EWING, NJ

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Codexis, Inc. Chemicals | Redwood City, CA

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Enzymotec Ltd. Biotechnology | Migdal HaEmeq, HZ

Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. It products include Infat, K-Real, Enzyp PS solutions, Vayaog, Vayarin, Vayarol, Nocoplex, Noctop for kids and Luciplex. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Teva Pharmaceutical Industries Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Teva Pharmaceutical Industries Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Teva Pharmaceutical Industries Ltd..